GB9806666D0 - Antigen preparation and use - Google Patents

Antigen preparation and use

Info

Publication number
GB9806666D0
GB9806666D0 GBGB9806666.5A GB9806666A GB9806666D0 GB 9806666 D0 GB9806666 D0 GB 9806666D0 GB 9806666 A GB9806666 A GB 9806666A GB 9806666 D0 GB9806666 D0 GB 9806666D0
Authority
GB
United Kingdom
Prior art keywords
antigen preparation
antigen
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9806666.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STANLEY MARGARET
Original Assignee
STANLEY MARGARET
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STANLEY MARGARET filed Critical STANLEY MARGARET
Priority to GBGB9806666.5A priority Critical patent/GB9806666D0/en
Publication of GB9806666D0 publication Critical patent/GB9806666D0/en
Priority to EP99913478A priority patent/EP1066391A2/en
Priority to PCT/GB1999/000978 priority patent/WO1999050424A2/en
Priority to AU31594/99A priority patent/AU3159499A/en
Priority to US10/029,430 priority patent/US20020193565A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
GBGB9806666.5A 1998-03-27 1998-03-27 Antigen preparation and use Ceased GB9806666D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9806666.5A GB9806666D0 (en) 1998-03-27 1998-03-27 Antigen preparation and use
EP99913478A EP1066391A2 (en) 1998-03-27 1999-03-29 Antigen preparation and use
PCT/GB1999/000978 WO1999050424A2 (en) 1998-03-27 1999-03-29 Fusion protein comprising a sequence from a major coat protein of a papovavirus
AU31594/99A AU3159499A (en) 1998-03-27 1999-03-29 Antigen preparation and use
US10/029,430 US20020193565A1 (en) 1998-03-27 2001-12-18 Antigen preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806666.5A GB9806666D0 (en) 1998-03-27 1998-03-27 Antigen preparation and use

Publications (1)

Publication Number Publication Date
GB9806666D0 true GB9806666D0 (en) 1998-05-27

Family

ID=10829441

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9806666.5A Ceased GB9806666D0 (en) 1998-03-27 1998-03-27 Antigen preparation and use

Country Status (4)

Country Link
EP (1) EP1066391A2 (en)
AU (1) AU3159499A (en)
GB (1) GB9806666D0 (en)
WO (1) WO1999050424A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE357252T1 (en) 1998-10-16 2007-04-15 Glaxosmithkline Biolog Sa ADJUVANCE SYSTEMS AND VACCINES
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
WO2001002551A2 (en) * 1999-06-30 2001-01-11 Evotec Oai Ag Virus like particles, preparation and use in screening and functional genomics
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
DE19952957B4 (en) * 1999-11-03 2006-08-31 Acgt Progenomics Ag Modular transport systems for molecular substances and their preparation and use
CN1114690C (en) 2001-05-15 2003-07-16 乔良 Papilloma pseudovirus and process for preparing same
GB0206360D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206359D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
ES2431963T3 (en) 2002-07-05 2013-11-28 Folia Biotech Inc. Adjuvant Viral Particle
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
GB0228715D0 (en) * 2002-12-09 2003-01-15 Glaxosmithkline Biolog Sa Vaccine
US7858098B2 (en) 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
US7758866B2 (en) 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
AU2006236905B2 (en) 2005-04-15 2010-06-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
DE102006041970A1 (en) * 2006-08-28 2008-03-06 Genome Identification Diagnostics Gmbh Method and means for detecting human papillomavirus
CZ2008565A3 (en) * 2008-09-15 2009-11-18 Vysoká škola chemicko technologická v Praze Preparation of monoclonal antibodies against FoxP3 protein using modified virus resembling particles of Mason-Pfizer ape virus
EP2377879A1 (en) * 2010-04-14 2011-10-19 Deutsches Krebsforschungszentrum N-terminal HPV E7 fusion proteins
MY202196A (en) 2017-06-23 2024-04-16 Verimmune Inc Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
WO2020139978A1 (en) 2018-12-27 2020-07-02 Verimmune Llc Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9106105U1 (en) * 1991-05-17 1991-09-26 Behringwerke Ag, 3550 Marburg, De
AUPM358894A0 (en) * 1994-01-31 1994-02-24 Csl Limited Modified papilloma virus l2 protein and vlps formed therefrom
GB9420146D0 (en) * 1994-10-06 1994-11-23 Cancer Res Campaign Tech Papillomavirus vaccine
DE19526752C2 (en) * 1995-07-21 1997-08-07 Lutz Prof Dr Gissmann Highly efficient formation of particles similar to papillomavirus
ES2264563T3 (en) * 1994-10-07 2007-01-01 Loyola University Of Chicago PARTICLES SIMILAR TO THE PAPILOMA VIRUS, FUSION PROTEINS AND PROCEDURE FOR PREPARATION.
US6228368B1 (en) * 1997-10-06 2001-05-08 Loyola University Of Chicago Papilloma virus capsomere formulations and method of use

Also Published As

Publication number Publication date
WO1999050424A2 (en) 1999-10-07
WO1999050424A3 (en) 1999-12-02
EP1066391A2 (en) 2001-01-10
AU3159499A (en) 1999-10-18

Similar Documents

Publication Publication Date Title
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
IL126811A0 (en) Human b-cell antigens and related reagents
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
ZA982478B (en) Compounds their use and preparation
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL136308A0 (en) Antipicornaviral compounds and methods for their use and preparation
GB9806666D0 (en) Antigen preparation and use
GB9813271D0 (en) Composition and use
IL138609A0 (en) Antipicornaviral compounds, their preparation and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
GB9702354D0 (en) Compounds and their use
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
CZ20011896A3 (en) Immunogenic preparation and antibody
EP1080102A4 (en) Antigens and their detection
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
PL328334A1 (en) Preparation and application thereof
DE29711429U1 (en) Beverage preparation and beverage made therefrom
GB9929581D0 (en) Comjpositions and their use
EP1066051A4 (en) Sciellin and uses thereof
HU9800542D0 (en) Epoxy-azetidinones, preparation and use thereof
GB9800760D0 (en) Antigens
GB9816014D0 (en) Piperidinecarboxamides and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)